24 Juni 2019 12:36 PM Eastern Daylight Time

BUSINESS WIRE

SpeeDx anuncia um contrato de colaboração com a GSK para o fornecimento de testes e tecnologia

In voller Größe anschauen

Opens in new window

Download-Formate

Volle Größe JPEG, 5536x1591, 474.0 KB
Klein JPEG, 480x138, 28.2 KB
Vorschau im JPEG-Format JPEG, 144x41, 5.3 KB
Kleinbild im JPEG-Format JPEG, 120x34, 4.3 KB

Smart Multimedia-Galerie

“SpeeDx has a demonstrated commitment to improve patient care, and our tests currently used in clinical practice are supporting Resistance Guided Therapy, positively impacting cure rates and helping to minimise the spread of antimicrobial resistant infections.” Colin Denver, SpeeDx CEO. (Photo: Business Wire)

“SpeeDx has a demonstrated commitment to improve patient care, and our tests currently used in clinical practice are supporting Resistance Guided Therapy, positively impacting cure rates and helping to minimise the spread of antimicrobial resistant infections.” Colin Denver, SpeeDx CEO. (Photo: Business Wire)

View and Share Foto

http://www.businesswire.de/multimedia/de/20190624005533/pt/4590921/

Share

E-Mail

Alle Nachrichten | Nachrichten mit Fotos & Multimedia > Pressemitteilung: SpeeDx anuncia um contrato de colaboração com a...

Weitere Business Wire-Websites